Clinical Trials Browser

Phase 2 × Drug-Related Side Effects and Adverse Reactions × pazopanib × Clear all

NCT02324803 2014-12-24

Phase II Study of Pazopanib as Second-line Treatment After Sunitinib in mRCC Patients

Phase 2 Unknown

Carcinoma, Renal Cell, Drug-Related Side Effects and Adverse Reactions